Product Images Mesalamine

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 2 images provide visual information about the product associated with Mesalamine NDC 68382-484 by Zydus Pharmaceuticals (usa) Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Mesalamine Tablets - 0325121b d673 4251 8d7d f9e79869afe8 01

Mesalamine Tablets - 0325121b d673 4251 8d7d f9e79869afe8 01

Mesalamine Tablets - 0325121b d673 4251 8d7d f9e79869afe8 02

Mesalamine Tablets - 0325121b d673 4251 8d7d f9e79869afe8 02

This is a description of a medication - Mesalamine, used for the treatment of moderately active ulcerative colitis. It is only available through a prescription, and each delayed-release tablet contains 800 mg of Mesalamine. The recommended dosage for adults is two 800 mg tablets to be taken three times daily with or without food for a total daily dose of 4.8 grams for a duration of 6 weeks. The tablet should not be chewed, crushed, or broken and should be swallowed whole with water. The medication comes in a package with full prescribing information. The medication is distributed by Zydus Pharmaceuticals USA Inc. The package should be stored at a controlled room temperature of 20°C to 25°C.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.